Klineo
Seedtable Score
37
Startups
1
Funding Rounds
3
Investors
$2.14m
Money raised
Overview
Klineo, based in Paris, is an AI-powered platform aimed at revolutionizing clinical trials through automation and optimization. Its B2B SaaS model addresses significant industry pain points like manual data entry, traditional monitoring methods, and inefficient software. By leveraging AI, Klineo seeks to accelerate trial completion times, reduce costs, and minimize errors, offering a substantial competitive edge. Supported by investors such as Pfizer Healthcare Hub: London, Bpifrance, and Wilco, Klineo is well-positioned to capture significant market share and drive innovation in clinical trials.
- Website: https://klineo.fr
- Business model: b2b, saas
- Company size: 1 - 11 employees
- Headquarters: Paris, France
- Founded: 2021
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Klineo has raised a total of $2.14m in funding over 1 rounds.
Key Insights:
- Seed: $2.14m
Klineo Seed (2024, $2M)
$2.14m